News | July 02, 2024
Abbott and YRGCARE inaugurate new outreach centers in India
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
The special Tele MANAS cell to serve as a dedicated mental health assistance helpline for all Armed Forces beneficiaries across country
Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Pivotal OASIS 1 and 2 Phase III studies of investigational compound elinzanetant achieved a statistically significant reduction in frequency and severity of vasomotor symptoms
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
Breakthrough Therapy designation for pain associated with DPN granted by FDA
Around 7% of the Indian population suffers from IBS
Subscribe To Our Newsletter & Stay Updated
